These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28373100)

  • 1. Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles.
    Labala S; Jose A; Chawla SR; Khan MS; Bhatnagar S; Kulkarni OP; Venuganti VVK
    Int J Pharm; 2017 Jun; 525(2):407-417. PubMed ID: 28373100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma.
    Labala S; Mandapalli PK; Kurumaddali A; Venuganti VV
    Mol Pharm; 2015 Mar; 12(3):878-88. PubMed ID: 25587849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous iontophoretic delivery of STAT3 siRNA using layer-by-layer chitosan coated gold nanoparticles to treat melanoma.
    Labala S; Jose A; Venuganti VV
    Colloids Surf B Biointerfaces; 2016 Oct; 146():188-97. PubMed ID: 27318964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes.
    Jose A; Labala S; Ninave KM; Gade SK; Venuganti VVK
    AAPS PharmSciTech; 2018 Jan; 19(1):166-175. PubMed ID: 28639178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer.
    Jose A; Labala S; Venuganti VV
    J Drug Target; 2017 Apr; 25(4):330-341. PubMed ID: 27819148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized LbL Film for Localized Delivery of STAT3 siRNA and Oxaliplatin Combination to Treat Colon Cancer.
    Janardhanam LSL; Bandi SP; Venuganti VVK
    ACS Appl Mater Interfaces; 2022 Mar; 14(8):10030-10046. PubMed ID: 35170934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles.
    Pan J; Ruan W; Qin M; Long Y; Wan T; Yu K; Zhai Y; Wu C; Xu Y
    Sci Rep; 2018 Jan; 8(1):1117. PubMed ID: 29348670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma Cancer Immunotherapy Using PD-L1 siRNA and Imatinib Promotes Cancer-Immunity Cycle.
    Li C; Han X
    Pharm Res; 2020 May; 37(6):109. PubMed ID: 32476052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
    Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A
    Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of interferons and siRNA targeting STAT3 using lentiviral vectors suppresses the growth of murine melanoma.
    Wang X; Liu P; Liu H; Yang W; Liu Z; Zhuo Z; Gao Y
    Cancer Gene Ther; 2012 Dec; 19(12):822-7. PubMed ID: 23018621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo.
    Das J; Das S; Paul A; Samadder A; Bhattacharyya SS; Khuda-Bukhsh AR
    Toxicol Lett; 2014 Mar; 225(3):454-66. PubMed ID: 24440344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
    Yi Y; Kim HJ; Zheng M; Mi P; Naito M; Kim BS; Min HS; Hayashi K; Perche F; Toh K; Liu X; Mochida Y; Kinoh H; Cabral H; Miyata K; Kataoka K
    J Control Release; 2019 Feb; 295():268-277. PubMed ID: 30639386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
    Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
    Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells.
    Rostami N; Nikkhoo A; Khazaei-Poul Y; Farhadi S; Sadat Haeri M; Moghadaszadeh Ardebili S; Aghaei Vanda N; Atyabi F; Namdar A; Baghaei M; Haghnavaz N; Kazemi T; Yousefi M; Ghalamfarsa G; Sabz G; Jadidi-Niaragh F
    J Cell Physiol; 2020 Dec; 235(12):9702-9717. PubMed ID: 32424937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles.
    Kim HJ; Takemoto H; Yi Y; Zheng M; Maeda Y; Chaya H; Hayashi K; Mi P; Pittella F; Christie RJ; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
    ACS Nano; 2014 Sep; 8(9):8979-91. PubMed ID: 25133608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.
    Emeagi PU; Maenhout S; Dang N; Heirman C; Thielemans K; Breckpot K
    Gene Ther; 2013 Nov; 20(11):1085-92. PubMed ID: 23804077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of charge on encapsulation and release behavior of small molecules in self-assembled layer-by-layer microcapsules.
    Mandapalli PK; Labala S; Vanamala D; Koranglekar MP; Sakimalla LA; Venuganti VV
    Drug Deliv; 2014 Dec; 21(8):605-14. PubMed ID: 24328418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Gold Nanoparticle Platform for the Delivery of Functional TGF-β1 siRNA Into Cancer Cells.
    Wu J; Liu B; Wu H; Wu Y; Zhang W; Zhao S; Zhang L; Pan X; Gao W; Wang X; Yuan Y; Zhang Y
    J Biomed Nanotechnol; 2016 Apr; 12(4):800-10. PubMed ID: 27301206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Layer-by-Layer Thin Films for Co-Delivery of TGF-β siRNA and Epidermal Growth Factor to Improve Excisional Wound Healing.
    Mandapalli PK; Labala S; Jose A; Bhatnagar S; Janupally R; Sriram D; Venuganti VV
    AAPS PharmSciTech; 2017 Apr; 18(3):809-820. PubMed ID: 27350274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.